← Urinary Tract Infection (UTI)
GC08.Z NICE NG109/NG111 / IDSA 2010 Strong recommendation; level A evidence for first-line agents

Bacterial infection of the bladder (cystitis) or upper tract (pyelonephritis). Most common pathogen: E. coli.

⚠ Red flags

  • Sepsis: HR >100, BP <90, confusion, lactate >2
  • Obstruction (stone, catheter block) — urgent decompression
  • Pregnancy — treat all bacteriuria including asymptomatic
  • Immunosuppression, transplant, or pregnancy with pyelonephritis — admit

Diagnostic criteria

Clinical

  • Lower UTI: dysuria, frequency, urgency, suprapubic pain
  • Upper UTI: fever, rigors, loin pain, nausea/vomiting

Investigations

  • Urine dipstick: nitrites and leucocytes (high sensitivity in symptomatic patients)
  • MSU culture and sensitivity (gold standard; send before antibiotics if complicated)

Investigations

Essential

  • MSU culture and sensitivity

Optional

  • FBC, CRP, U&E, creatinine if systemically unwell
  • Blood cultures if pyelonephritis or sepsis
  • Renal USS if recurrent UTI, suspected obstruction, or poor response
  • CT-KUB if stone or pyonephrosis suspected

Management

Acute

  • Pyelonephritis with sepsis: IV antibiotics, fluid resuscitation, source control

Long-term

  • Recurrent UTI: low-dose nightly prophylaxis (trimethoprim 100 mg or nitrofurantoin 50 mg) for 6 months
  • Vaginal oestrogen for post-menopausal recurrent UTI

Non-pharmacological

  • Encourage fluid intake (≥2 L/day)
  • Post-coital voiding; avoid spermicidal contraception in recurrent UTI

Pharmacological

DrugDoseNotes
Nitrofurantoin 100 mg PO BD for 3 days (women) or 7 days (men) First-line uncomplicated cystitis. Avoid if eGFR <45.
Trimethoprim 200 mg PO BD for 3–7 days Alternative; avoid in 1st trimester pregnancy and check local resistance.
Ciprofloxacin 500 mg PO BD for 7 days For complicated UTI / outpatient pyelonephritis. Tendon and QT risks; avoid in pregnancy.
Ceftriaxone (IV) 1–2 g IV once daily Inpatient pyelonephritis; switch to oral when sensitivities known and patient stable.

Monitoring

  • Symptom resolution within 48–72h of antibiotics
  • Test of cure culture only in pregnancy, recurrent UTI, or pyelonephritis

Referral criteria

  • Recurrent UTI ≥3 episodes/year
  • Suspected upper tract obstruction or stones
  • Persistent haematuria after treatment (urology — exclude malignancy)
  • Pregnancy with pyelonephritis

Complications

  • Pyelonephritis, perinephric abscess
  • Urosepsis
  • Renal scarring (especially in children with VUR)
  • Preterm labour (untreated UTI in pregnancy)

Special populations

Pregnancy
Treat asymptomatic bacteriuria. Avoid trimethoprim in 1st trimester (folate antagonist), nitrofurantoin near term (haemolysis). Cefalexin generally safe.
Renal impairment
Avoid nitrofurantoin if eGFR <45. Adjust ciprofloxacin and beta-lactam doses.
Hepatic impairment
Most antibiotics safe; review co-amoxiclav use in active liver disease.
Elderly
Asymptomatic bacteriuria common — do NOT treat unless symptomatic. Beware atypical presentation (delirium).
Paediatric
Send clean-catch MSU; consider USS in <6 months or recurrent UTI to look for VUR.
Clinical guidelines summary. Cross-check with the latest source.